(1 - 14 from 67
)
Infinity Augments Executive Leadership Team, Appointing ...
www.nbcnews.com
Nov 8, — ... chair over the past year, I have been committed to ensuring a smooth leadership transition to Infinity's new CEO, Adelene Perkins. › wbna
Troubled Infinity licenses cancer drug to Verastem
www.biopharmadive.com
Nov 3, — ... capabilities and deep knowledge of the tumor microenvironment,” Infinity CEO Adelene Perkins said in the November 2 statement. Jun 14, — ... as we explore options for duvelisib and the advancement of IPI-549, our second clinical program,” said Adelene Perkins, CEO of Infinity. › news › Infinity-duve... › news › infinity-phar...
Duvelisib meets primary endpoint in indolent non–Hodgkin lymphoma
www.healio.com
... clinical benefit for patients with advanced indolent non–Hodgkin lymphoma, a difficult-to-treat disease,” Adelene Perkins, president and CEO ...
Infinity Pharma Pulls Plug On Cancer Drug Saridegib Trials, Shares...
www.rttnews.com
Adelene Perkins, president and CEO of Infinity said, " While this news is disappointing, these disappointments are an inherent part of our ...
sorted by relevance / date